Articulate Biosciences
Lowell
About Articulate Biosciences
Articulate Biosciences develops viscoelastic gels for injection to treat arthritis and other soft tissue diseases. The company is a preclinical stage medical device company that was spun out of Boston University in 2016.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $224.9K
- Last round: Grant (Jun 2018)
- Website: articulatebio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/articulate-biosciences-148516 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.